Development of nuclease-mediated site-specific genome modification
- 1 October 2012
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 24 (5), 609-616
- https://doi.org/10.1016/j.coi.2012.08.005
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Stem-Cell Gene Therapy for the Wiskott–Aldrich SyndromeNew England Journal of Medicine, 2010
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010
- 20 years of gene therapy for SCIDNature Immunology, 2010
- Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous diseaseNature Medicine, 2010
- Progress and prospects: gene therapy for inherited immunodeficienciesGene Therapy, 2009
- Chimeric Nucleases Stimulate Gene Targeting in Human CellsScience, 2003
- Targeted mutation of the Hprt gene in mouse embryonic stem cells.Proceedings of the National Academy of Sciences, 1988
- Targetted correction of a mutant HPRT gene in mouse embryonic stem cellsNature, 1987
- Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cellsCell, 1987
- Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombinationNature, 1985